Pfizer Assails Janssen Suit Over Remicade Biosimilar
Janssen Biotech Inc.'s patent suit over a biosimilar version of its blockbuster biologic Remicade must be tossed because the suit wasn't filed by all of the patent's co-owners, Pfizer Inc. told...To view the full article, register now.
Already a subscriber? Click here to view full article